Clinical trial
Levetiracetam in Central Pain in Multiple Sclerosis(MS)
NCT00423527 · Odense University Hospital, Other · Completed
Key facts
| NCT number | NCT00423527 |
|---|---|
| Title | Levetiracetam in Central Pain in Multiple Sclerosis(MS) |
| Official title | Double-blind, Randomised,Placebo-controlled Trial of Levetiracetam in Central Pain in Multiple Sclerosis |
| Lead sponsor | Odense University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | levetiracetam |
| Enrollment | 30 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jan 18, 2007 |
| Last update posted | Dec 18, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: